ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

PET/CT Alone Should Not Be Used to Exclude Tonsillar Cancer

by Amy E. Hamaker • January 7, 2019

  • Tweet
  • Email
Print-Friendly Version

You Might Also Like

  • HN Cancer Patients with Negative Imaging History Derive Limited Benefit from Subsequent PET-CT
  • Survival for Advanced Head, Neck Cancer Improvements May Be Related to PET
  • PET Not Ready for Routine Management of Head and Neck Cancer
  • PET/CT Useful for Head and Neck Cancers, with Limitations
Explore This Issue
January 2019

Comment: Increased and asymmetric PET/CT FDG uptake in the tonsils is a frequent reason for referral to otolaryngology. However, it is unclear what uptake threshold should prompt biopsy. Certainly, we don’t want to miss primary tonsillar cancer; we also don’t want to perform unnecessary procedures. This small study showed that an SUVmax ratio between tonsils >1.6 (62% sensitive, 100% specific) is highly suspicious and warrants biopsy. They also note that malignant tonsils can have normal FDG uptake. Thus, PET/CT alone should not be used to exclude
cancer. —Jennifer Villwock, MD

What is the maximum standardized uptake value (SUVmax) ratio between tonsils in patients with and without tonsillar carcinoma to determine useful diagnostic thresholds?

Bottom Line:
An SUVmax ratio between tonsils of ≥1.6 is highly suspicious for squamous cell carcinoma (SCC) and could be used to direct site of biopsy. Some malignant tonsils had normal FDG uptake; therefore, positron-emission tomography (PET)/computed tomography (CT) should not be used to exclude tonsillar cancer. Minor asymmetrical uptake is frequently seen in non-malignant tonsils and does not necessarily require further investigation.

Study design: Retrospective.

Summary: PET/CT examinations of patients with suspected head and neck SCC and controls from April 2013 to September 2016 were reviewed retrospectively. Tonsillar SUVmax ratios (ipsilateral/contralateral for malignant tonsils, maximum/minimum for patients without [controls]) were calculated and used to construct a receiver operating characteristic (ROC) curve. Twenty-five patients had tonsillar carcinoma (mean SUVmax ratio of 2, range 0.89–5.4) and 86 patients acted as controls (mean SUVmax ratio of 1.1, range 1–1.5). Using the ROC, the most accurate SUVmax ratio for identifying malignancy was >1.2 (77% sensitivity, 86% specificity). A potentially more clinically useful SUVmax ratio is ≥1.6 with 62% sensitivity and 100% specificity.

Citation: Pencharz D, Dunn J, Connor S, et al. Palatine tonsil SUVmax on FDG PET-CT as a discriminator between benign and malignant tonsils in patients with and without head and neck squamous cell carcinoma of unknown primary. Clin Radiol. Published November 16, 2018 online ahead of print. doi: 10.1016/j.crad.2018.10.007.

Filed Under: Head and Neck, Head and Neck, Literature Reviews, Practice Focus Tagged With: head and neck cancer, PET-CT, tonsillar cancerIssue: January 2019

You Might Also Like:

  • HN Cancer Patients with Negative Imaging History Derive Limited Benefit from Subsequent PET-CT
  • Survival for Advanced Head, Neck Cancer Improvements May Be Related to PET
  • PET Not Ready for Routine Management of Head and Neck Cancer
  • PET/CT Useful for Head and Neck Cancers, with Limitations

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Otolaryngologists Have a Major Role to Play in Treating COVID-19 Long-Haulers
    • Weaning Patients Off of PPIs
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.